NCT05899413

Brief Summary

This study aims to understand the role of the vagus nerve in promoting social bonding by using a non-invasive stimulation technique called transcutaneous vagal nerve stimulation (tVNS). The investigators will investigate whether tVNS can improve emotional, physiological, and behavioral experiences during and after social interactions. Couples will be randomly assigned to receive either tVNS or a sham stimulation during gratitude expression and problem-solving discussions. The investigators will measure their subjective evaluations of the interactions and capture their physiological and behavioral synchrony. This research will shed light on the processes involved in social connection and explore the potential of tVNS as a tool to enhance bonding in close relationships.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

June 12, 2023

Completed
8 months until next milestone

Study Start

First participant enrolled

February 17, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2024

Completed
9 months until next milestone

Results Posted

Study results publicly available

May 4, 2025

Completed
Last Updated

May 4, 2025

Status Verified

April 1, 2025

Enrollment Period

6 months

First QC Date

May 24, 2023

Results QC Date

March 26, 2025

Last Update Submit

April 22, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Self-reported Positive Affect

    During the conversation, overall, I felt… (1: not at all positive, 7: extremely positive)

    Once, self-reported in a survey immediately following conflict interaction, up to 10 minutes

  • Self-reported Negative Affect

    During the conversation, overall, I felt… (1: not at all negative, 7: extremely negative)

    Once, self-reported in a survey immediately following conflict interaction, up to 10 minutes

  • Respiratory Sinus Arrhythmia

    RSA was assessed continuously throughout the conversation.

    Continuously throughout conflict conversation

  • Interbeat Interval

    IBI was assessed continuously throughout the conversation.

    Continuously throughout the conflict conversation

Study Arms (2)

Active tVNS

EXPERIMENTAL

We will use a research edition of an auricular vagus nerve stimulator (tVNS RE, Vagus.net™, UK) that sends current-controlled stimulation in symmetric biphasic waveforms. The tVNS RE conforms to EU directive 93/42/EEC medical device standards and ISO/IEC 17050-1. This device consists of a handheld stimulator and an electrode clip. We will deliver stimulation at the individually calibrated intensity continuously during the interactions, and the default device settings we adopted were as follows: frequency = 30Hz, phase duration = 250μs, interphase interval = 50μs, and max voltage = 65V. In the active stimulation condition, both partners will have the stimulation clip attached to the outer auditory canal.

Device: Transcutaneous vagal nerve stimulation

Sham tVNS

SHAM COMPARATOR

In the sham condition, both partners will have electrodes attached to the center of the left ear lobe. They will still receive stimulation but at a placement that should not activate the vagus nerve.

Device: Transcutaneous vagal nerve stimulation

Interventions

The intervention consists of neurostimulation device that is programmed to a stimulus intensity at 0.5mA with a stimulation frequency of 25 Hz at the outer auditory canal.

Active tVNSSham tVNS

Eligibility Criteria

Age18 Years - 39 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Fluent in English
  • Having been in a relationship with the partner for at least a year
  • Within the age range of 18-39

You may not qualify if:

  • Major chronic disease. self-reported autoimmune disease; severe asthma; lung disease (such as chronic bronchitis; history of stroke, heart attack, epilepsy, brain injury); cardiovascular disease.
  • Cancer: if not in remission.
  • Substance dependence-current or long history (5 years of more).
  • Current psychiatric diagnosis that is not being treated with medication
  • Confounding medications, including those used to treat hypertension and cardiovascular conditions; psychoactive substances; and medications known to directly affect autonomic functioning.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSF Nancy Friend Pritzker Psychiatry Building

San Francisco, California, 94107, United States

Location

Related Publications (1)

  • Chung JM, Harari GM, Denissen JJ. Investigating the within-person structure and correlates of emotional experiences in everyday life using an emotion family approach. Journal of Personality and Social Psychology. 2022;122(6):1146-1189.

    BACKGROUND

Results Point of Contact

Title
Dr. Yoobin Park
Organization
University of California, San Francisco

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participant couples will be blinded to their condition. Experimenters running the study will not be blinded since tVNS administration currently requires their knowledge of the condition.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Couple dyads will be randomly assigned to receive either tVNS or sham stimulation.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2023

First Posted

June 12, 2023

Study Start

February 17, 2024

Primary Completion

July 31, 2024

Study Completion

July 31, 2024

Last Updated

May 4, 2025

Results First Posted

May 4, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

There is currently no plan to make individual participant data available to other researchers.

Locations